The healthcare-focused SPAC said net proceeds of $10.5 million from the exercise of the over-allotment option bring total assets to $413.2 million. Read more.
Related Posts
SportsMap Tech Acquisition Files for $100M IPO
The new SPAC will focus on companies engaged in sports technologies, including fan engagement, health and wellness, Esports, and fantasy sports and gambling.
Nuvation Bio Closes Transaction with Panacea
Panacea shareholders approved the $644 million merger yesterday.
Forum Merger IV Prices $300M IPO
Forum Merger IV will search for companies with an aggregate enterprise value of approximately $500 million to $5 billion or more that are based in North America or Western Europe.
HighCape Capital Acquisition II Pulls Plug on $200M IPO
HighCape had planned to focus on companies engaged in life sciences and life sciences related industries.